Free Trial

Nevro (NVRO) Competitors

Nevro logo
$5.85 +0.01 (+0.10%)
Closing price 04/2/2025
Extended Trading
$5.85 0.00 (0.00%)
As of 04/2/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NVRO vs. EYE, AXGN, EMBC, BVS, RXST, CBLL, IRMD, AVNS, SIBN, and KIDS

Should you be buying Nevro stock or one of its competitors? The main competitors of Nevro include National Vision (EYE), AxoGen (AXGN), Embecta (EMBC), Bioventus (BVS), RxSight (RXST), CeriBell (CBLL), Iradimed (IRMD), Avanos Medical (AVNS), SI-BONE (SIBN), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry.

Nevro vs.

National Vision (NASDAQ:EYE) and Nevro (NYSE:NVRO) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, community ranking, earnings and dividends.

National Vision has a net margin of -0.81% compared to Nevro's net margin of -16.54%. National Vision's return on equity of 3.52% beat Nevro's return on equity.

Company Net Margins Return on Equity Return on Assets
National Vision-0.81% 3.52% 1.39%
Nevro -16.54%-23.52%-10.83%

National Vision has higher revenue and earnings than Nevro. National Vision is trading at a lower price-to-earnings ratio than Nevro, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
National Vision$1.82B0.50-$65.90M-$0.36-32.39
Nevro$408.52M0.55-$92.21M-$3.05-1.92

National Vision has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500. Comparatively, Nevro has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500.

Nevro received 250 more outperform votes than National Vision when rated by MarketBeat users. However, 64.80% of users gave National Vision an outperform vote while only 62.38% of users gave Nevro an outperform vote.

CompanyUnderperformOutperform
National VisionOutperform Votes
254
64.80%
Underperform Votes
138
35.20%
NevroOutperform Votes
504
62.38%
Underperform Votes
304
37.62%

National Vision presently has a consensus target price of $14.00, suggesting a potential upside of 20.07%. Nevro has a consensus target price of $5.36, suggesting a potential downside of 8.29%. Given National Vision's stronger consensus rating and higher probable upside, research analysts plainly believe National Vision is more favorable than Nevro.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Vision
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.17
Nevro
2 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.92

In the previous week, National Vision had 5 more articles in the media than Nevro. MarketBeat recorded 7 mentions for National Vision and 2 mentions for Nevro. National Vision's average media sentiment score of 1.37 beat Nevro's score of 0.23 indicating that National Vision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
National Vision
6 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nevro
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

95.5% of Nevro shares are owned by institutional investors. 2.3% of National Vision shares are owned by insiders. Comparatively, 3.2% of Nevro shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

National Vision beats Nevro on 12 of the 17 factors compared between the two stocks.

Remove Ads
Get Nevro News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVRO vs. The Competition

MetricNevroSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$224.32M$4.06B$5.33B$18.52B
Dividend YieldN/A39.50%5.11%4.23%
P/E Ratio-3.0927.6321.7331.15
Price / Sales0.5550.20379.2025.69
Price / CashN/A51.0838.1517.53
Price / Book0.725.826.464.29
Net Income-$92.21M$67.09M$3.20B$1.02B
7 Day PerformanceN/A-0.17%2.85%-0.79%
1 Month Performance0.88%-3.20%-8.55%-6.88%
1 Year Performance-53.93%14.84%10.46%1.74%

Nevro Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVRO
Nevro
0.8695 of 5 stars
$5.85
+0.1%
$5.36
-8.3%
-53.2%$224.32M$408.52M-3.091,090Analyst Forecast
News Coverage
EYE
National Vision
2.0503 of 5 stars
$11.35
+0.4%
$14.00
+23.3%
-39.3%$894.19M$1.82B-56.7514,000Positive News
Gap Down
AXGN
AxoGen
2.9597 of 5 stars
$16.62
+2.5%
$22.60
+36.0%
+122.6%$737.00M$187.34M-51.94450Short Interest ↑
News Coverage
Positive News
Gap Down
EMBC
Embecta
4.5228 of 5 stars
$12.09
+0.8%
$23.00
+90.2%
+12.5%$702.84M$1.11B12.091,900Gap Down
High Trading Volume
BVS
Bioventus
3.1717 of 5 stars
$8.27
-0.7%
$15.00
+81.4%
+67.2%$677.68M$573.28M-13.561,200News Coverage
Positive News
Gap Down
RXST
RxSight
3.0248 of 5 stars
$16.61
+2.2%
$43.78
+163.6%
-72.5%$672.56M$139.93M-20.01220Analyst Forecast
Gap Down
High Trading Volume
CBLL
CeriBell
N/A$18.19
-1.4%
$32.50
+78.7%
N/A$652.44M$65.44M0.00N/ANews Coverage
Gap Down
IRMD
Iradimed
4.8759 of 5 stars
$49.37
-1.1%
$72.00
+45.8%
+27.1%$627.74M$73.24M32.91110Short Interest ↓
News Coverage
Positive News
AVNS
Avanos Medical
3.1827 of 5 stars
$12.88
-4.0%
N/A-36.1%$592.43M$687.80M37.884,040Positive News
High Trading Volume
SIBN
SI-BONE
4.0648 of 5 stars
$13.47
flat
$24.40
+81.1%
-14.5%$571.84M$167.18M-14.64350Positive News
Gap Down
KIDS
OrthoPediatrics
4.3197 of 5 stars
$21.80
-4.0%
$37.20
+70.6%
-31.1%$529.46M$204.73M-17.72200Positive News
High Trading Volume
Remove Ads

Related Companies and Tools


This page (NYSE:NVRO) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners